Moody's assigns R1 RCM Ba2 CFR and Ba2 sr. sec. ratings; outlook stable
Moody's Investors Service ("Moody's") assigned ratings to R1 RCM Inc. ("R1"), including a Ba2 corporate family rating ("CFR"), Ba2-PD probability of default rating ("PDR"), and Ba2 instrument ratings to the healthcare revenue cycle management ("RCM") company's senior secured first-lien credit facili...R1 RCM is a provider of revenue cycle management (RCM) services to healthcare providers, including health systems and hospitals, physicians groups, and municipal and private emergency medical service (EMS) providers. The company manages healthcare providers' revenue cycle operations, which encompass processes including patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation and collections from patients and payers. The company's primary service offering consists of end-to-end RCM services for health systems, hospitals, physician groups, and EMS providers, which the company deploys through an operating partner relationship or a co-managed relationship.
Moody's Investors Service is a leading provider of credit ratings, research, and risk analysis. Moody's commitment and expertise contributes to transparent and integrated financial markets, protecting the integrity of credit. Our ratings and analysis track debt covering more than:
- 130 countries
11,000 corporate issuers
21,000 public finance issuers
76,000 structured finance obligations
Credit ratings and research help investors analyze the credit risks associated with fixed-income securities. Such independent credit ratings and research also contribute to efficiencies in fixed-income markets and other obligations, such as insurance policies and derivative transactions, by providing credible and independent assessments of credit risk.
Moody’s default studies validate our predictive ratings. Our published research and investor briefings draw thousands of attendees each year and keep investors current with the rationale underlying our credit opinions.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.